Will the people with demyelinating diseases ever be able to use CAR Treg cells to be cured, if it proves effective in the future? Probably not, considering its gigantic price. Researchers should focus on developing an affordable safe Treg-specific viral vector to produce CAR Treg’s in-vivo.